Impact of global versus renal-specific sympathoinhibition in aldosterone-induced hypertension: implications for medical device-based treatment of resistant hypertension

Hypertension. 2015 Jun;65(6):1160-2. doi: 10.1161/HYPERTENSIONAHA.115.05228. Epub 2015 Apr 20.

Authors

Casey Y Carmichael¹, Richard D Wainford²

Affiliations

¹ From the Department of Pharmacology and Experimental Therapeutics and the Whitaker Cardiovascular Institute, Boston University School of Medicine, MA.
² From the Department of Pharmacology and Experimental Therapeutics and the Whitaker Cardiovascular Institute, Boston University School of Medicine, MA. rwainf@bu.edu.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Aldosterone / pharmacology*
Animals
Baroreflex / physiology*
Hypertension / surgery*
Male
Norepinephrine / blood*
Renin-Angiotensin System / drug effects*

Substances

Aldosterone
Norepinephrine

Grants and funding